. 2023 Jan 25;14:1083145. doi: 10.3389/fendo.2023.1083145

Table 3.

Research and clinical recommendations for CGM use in marginalized populations as a component of diabetes virtual care.

Domain	Specific Recommendations
Research Recommendations	1. Characterize the rates of CGM use within marginalized groups with T1D and T2D, including Black or African American, Native American, Latinx American, and Asian American groups. 2. Characterize the effect of CGM use on diabetes-related clinical, behavioral, and psychosocial outcomes within marginalized groups, including Black or African American, Native American, Latinx American, and Asian American groups. 3. Conduct qualitative research to understand diverse patient perspectives of CGM use and diabetes virtual care. 4. Design, evaluate, and implement culturally relevant and meaningful interventions for CGM use as a component of virtual care, based on the formative research, above, and in alignment with clinical practice guidelines
Clinical Recommendations	1. Develop population-based approaches to: a) systematically provide education about the option of CGM to all people with diabetes to support shared decision-making related to imitating CGM, and b) systematically identify patients who may qualify for CGM based on clinical practice guidelines, regardless of race, ethnicity, or other individual characteristic. 2. Deliver evidence-based and meaningful education and support programs for CGM initiation and maintenance that are tailored to the needs, preferences, and challenges of that individual and their community. 3. Design diabetes virtual care models to promote equity by involving marginalized community members in the planning and evaluation of virtual care to ensure the programs align with the community’s needs and preferences. 4. Incorporate CGM into diabetes virtual care to augment remote monitoring of blood glucose for providers and patients to leverage as a part of shared-decision-making, treatment planning, and daily diabetes management.

Domain

Specific Recommendations

Research Recommendations

1. Characterize the rates of CGM use within marginalized groups with T1D and T2D, including Black or African American, Native American, Latinx American, and Asian American groups.
2. Characterize the effect of CGM use on diabetes-related clinical, behavioral, and psychosocial outcomes within marginalized groups, including Black or African American, Native American, Latinx American, and Asian American groups.
3. Conduct qualitative research to understand diverse patient perspectives of CGM use and diabetes virtual care.
4. Design, evaluate, and implement culturally relevant and meaningful interventions for CGM use as a component of virtual care, based on the formative research, above, and in alignment with clinical practice guidelines

Clinical Recommendations

1. Develop population-based approaches to:
a) systematically provide education about the option of CGM to all people with diabetes to support shared decision-making related to imitating CGM, and
b) systematically identify patients who may qualify for CGM based on clinical practice guidelines, regardless of race, ethnicity, or other individual characteristic.
2. Deliver evidence-based and meaningful education and support programs for CGM initiation and maintenance that are tailored to the needs, preferences, and challenges of that individual and their community.
3. Design diabetes virtual care models to promote equity by involving marginalized community members in the planning and evaluation of virtual care to ensure the programs align with the community’s needs and preferences.
4. Incorporate CGM into diabetes virtual care to augment remote monitoring of blood glucose for providers and patients to leverage as a part of shared-decision-making, treatment planning, and daily diabetes management.

CGM, continuous glucose monitoring, T1D, type 1 diabetes, T2D, type 2 diabetes.